insights_auto
Zašto je ALNY skočio 3,63%?
Istražite detaljnijechevron_right
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
232,68 USD
arrow_upward
+3,63%(+8,15) 1D
232,68 USD
0,00% (0,00)
bedtimeNakon radnog vremena
Zatvoreno: 9. lis, 16:00:01 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za ALNY...
Otvori
224,74 USD
Najviša
232,94 USD
Najniža
222,70 USD
Trž. kap.
31,13 mlr.
Prosj. kol.
1,50 mil.
Količina
959,45 tis.
P/E omjer
39,60
52-tjed. najviša
495,55 USD
52-tjed. najniža
197,81 USD
EPS
5,88 USD
Beta
0,28
Dionice u optjecaju
133,81 mil.
Broj djelatnika
2 tis.
Otvori
224,74 USD
Najviša
232,94 USD
Najniža
222,70 USD
Trž. kap.
31,13 mlr.
Prosj. kol.
1,50 mil.
Količina
959,45 tis.
P/E omjer
39,60
52-tjed. najviša
495,55 USD
52-tjed. najniža
197,81 USD
EPS
5,88 USD
Beta
0,28
Dionice u optjecaju
133,81 mil.
Broj djelatnika
2 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Zacks
·
prije 11 sati
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
Zacks
·
prije 14 sati
EDIT Set to Begin First-in-Human Study in Hypercholesterolemia
Zacks
·
prije 15 sati
Viatris to Buy Pacira for $1.65B to Expand Non-Opioid Pain Portfolio
Zacks
·
prije 16 sati
ARGX Stock Down on Stopping Late-Stage Autoimmune Disease Study
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Alnylam Pharmaceuticals, Inc. – informacije
Glavni izvršni direktor-
Zaposlenici2,5 tis.
Osnovano14. lip 2002.
Sjedište-
Sektor-
Web-lokacijaalnylam.com